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Long term oxygen therapy is widely accepted as a treatment for severe hypoxaemia in 
patients with chronic respiratory disorders, based on survival findings from the UK Medical 
Research Council study[1] and the US Nocturnal Oxygen Therapy Trial[2].  The data from these 
landmark studies have driven the underlying rationale that correcting hypoxaemia is 
beneficial, and have led to the prescription of oxygen for other indications, including 
ambulatory oxygen for patients with exercise-induced oxygen desaturation (EID), nocturnal 
oxygen therapy for patients with nocturnal hypoxaemia and short burst oxygen for palliation 
of dyspnoea. This is despite a lack of supporting evidence from randomized clinical trials to 
support these indications[3-5].  
 
A clinical indication that stimulates long-standing debate is the specific use of supplemental 
oxygen during exercise training in patients with EID. There is a sound physiological rationale 
in that supplemental oxygen can reduce respiratory rate and dynamic hyperinflation[6]. It 
also improves oxygen delivery, leading to a reduction in exercise-associated metabolic 
acidosis [7]. More than sixty years ago, Cotes and colleagues demonstrated that ambulatory 
oxygen could support outpatients with chronic respiratory insufficiency during exercise by 
improving arterial oxygen saturation and increasing walking time[8]. Subsequent, largely 
laboratory-based, studies have demonstrated a positive, albeit heterogeneous, benefit in 
exercise time following acute administration of oxygen during an exercise test in patients with 
COPD or cystic fibrosis[9, 10]. This had led to the logical hypothesis that by improving exercise 
time acutely, supplemental oxygen allows patients to tolerate training sessions of higher 
intensity with consequently gain greater benefit from an exercise training programme. 
Although there have been attempts to provide evidence to support this hypothesis [11-14], 
the results from clinical trials have been mixed and inconclusive, largely due to 
methodological issues, small sample sizes and inclusion of a heterogeneous population, 
including existing long-term oxygen users [11] or individuals without EID [13, 14]. 
 
In this issue of the European Respiratory Journal, Alison and colleagues report on a double-
blind randomised placebo-controlled trial that aimed to determine whether supplemental 
oxygen administered during exercise training was more effective than medical air in 
improving endurance exercise capacity; health-related quality of life; peak walking capacity; 
dyspnoea and physical activity levels in patients with COPD who were normoxaemic at rest 
but desaturated during exercise (<90% during the six-minute walk test)[15]. Following 
random allocation to either oxygen or compressed air, both groups underwent an eight-week 
training programme with three supervised exercise sessions per week. Training initially 
consisted of 30 minutes of individualised aerobic exercise (20 minutes of treadmill walking 
and 10 minutes of stationary cycling). Training intensity was increased according to target 
dyspnoea scores (3-4 on modified dyspnoea scale [16]) and training duration was increased 
according to a fixed protocol. The results of this study demonstrated that both groups 
improved exercise capacity and health-related quality of life following exercise training, but 
no added benefit was seen with supplemental oxygen in either of the primary outcomes 
measures of endurance shuttle walk test and chronic respiratory questionnaire, nor in any of 
the secondary outcome measures. This was a well-designed and conducted study, with clear 
eligibility criteria, high retention of participants, and successful blinding of participants, 
trainers and assessors: a feature absent in previous trials[11-14].   
 
A fundamental observation was that the oxygen group were not able to achieve a greater 
training dose per session than the compressed air group, despite a significantly higher 
measured oxygen saturation and significantly lower dyspnoea and perceived exertion scores 
during treadmill training sessions. Without an increased training load, it was not altogether 
surprising that no between-group differences in response to exercise-training were observed. 
The authors speculated that the large physiological stimulus applied to both groups 
overwhelmed the small physiological advantage of acute oxygen administration. Although 
this is a highly plausible explanation (observed in previous pulmonary rehabilitation adjunct 
trials[17, 18]), other mechanisms may have limited exercise-training load. The authors did not 
provide data regarding leg effort or lower limb symptoms, which are reported frequently as 
a reason for terminating exercise in a proportion of patients with COPD[19]. The exercise-
training programme was protocolized such that exercise type and frequency were fixed and 
exercise duration was progressed up to a maximum of 40 minutes by week three. From this 
point onwards, staff supervising exercise-training could only increase training intensity (speed 
of treadmill and cycle workload) but not duration of training – the parameter that is most 
consistently influenced by acute oxygen response studies. Another speculative explanation is 
that because the trainers were blinded to treatment allocation and to patients’ oxygen 
saturation during training, they may have inadvertently been more cautious of increasing 
training intensity in patients known to desaturate during exercise (of whom half were using 
air). Circumstantial evidence to support this is the observation that the responses to exercise-
training in both groups, although statistically significant, were smaller than expected and did 
not achieve the minimum clinically important difference of the incremental shuttle walk test 
nor some domains of the Chronic Respiratory Questionnaire following the exercise-training 
programme.  
 Another important consideration is that most participants had moderate EID, and the trial 
was therefore underpowered to detect an effect of supplemental oxygen in patients with 
more severe EID (nadir below 80%). Furthermore, prior to the start of the exercise 
programme, the acute physiological response to oxygen was not tested, hence it is not clear 
as to the proportion of acute oxygen responders and non-responders in the treatment and 
control groups. Hence the results of the trial cannot be extrapolated to the specific subgroups 
of patients with COPD and severe EID, those who have shown a beneficial response to acute 
oxygen administration, nor patients with non-COPD disorders (such as idiopathic pulmonary 
fibrosis and pulmonary hypertension) and EID. Further research is required to understand the 
role of supplemental oxygen in the exercise-training of these patient subgroups. 
 
Alison and colleagues should be congratulated in rigorously conducting the largest study to 
date to examine the role of supplemental oxygen during exercise-training in patients with 
COPD and EID. They provide convincing data that the majority of patients with COPD and EID 
safely benefit from exercise-training without the need for supplemental oxygen. This supports 
the recommendations of international pulmonary rehabilitation guidelines that supplemental 
oxygen should not be routinely prescribed in patients with COPD who desaturate but do not 
fulfil indications for long-term oxygen therapy [20-22]. The findings therefore may help to  
simplify the assessment process of patients with EID for exercise-training interventions such 
as pulmonary rehabilitation. We present our current assessment algorithm prior to 
commencement of pulmonary rehabilitation (Figure 1), which acknowledges remaining 
uncertainty around the role of supplemental oxygen in specific patient subgroups, namely 
those who show an acute response to supplemental oxygen and those with severe EID. 
 Although Alison and colleagues intended to explore whether exercise-training or pulmonary 
rehabilitation in patients with EID could be enhanced with supplemental oxygen, perhaps the 
most important clinical implication of this study is that for the vast majority of patients, the 
non-availability of supplemental oxygen need not be a barrier to using community and non-
medical settings to deliver pulmonary rehabilitation. This potentially increases the 
accessibility, utilization and reach of an evidence-based intervention that is considerably 
more effective in reducing symptom burden in COPD than supplemental oxygen alone.  
 
  
Figure Legend 
 
Figure 1: An algorithm to assessing exercise induced oxygen desaturation (EID) (defined as 
nadir oxygen saturation below 90% during a field walking test performed on room air) in 
patients with COPD referred for pulmonary rehabilitation. 
  
  
 
 
 
Assessment for pulmonary 
rehabilitation
Existing formal prescription 
for long term or ambulatory 
oxygen therapy
Exercise-training on existing 
oxygen prescription
No EID
Exercise-training on room 
air
EID
EID with nadir between 80-
90%
Repeat field walking test on 
supplemental oxygen to 
keep oxygen saturation 
above 90% during exercise
Improvement in walking 
distance by at least 
minimum clinically 
important difference
? Consider exercise-training 
with supplemental oxygen
No significant improvement 
in walking distance
Exercise-training on room 
air
EID with nadir below 80%
? Consider exercise-training 
with supplemental oxygen
 
 
References: 
 
1. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic 
bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 
1981; 1(8222): 681-6. 
2. Nocturnal Oxygen Therapy Trial G, Continuous or Nocturnal Oxygen Therapy in Hypoxemic 
Chronic Obstructive Lung Disease: A Clinical Trial. Annals of Internal Medicine 1980; 93(3): 
391-398. 
3. Ameer F, Carson KV, Usmani ZA,Smith BJ, Ambulatory oxygen for people with chronic 
obstructive pulmonary disease who are not hypoxaemic at rest. Cochrane Database of 
Systematic Reviews 2014(6). 
4. Chaouat A, Weitzenblum E, Kessler R, Charpentier C, Enrhart M, Schott R, Levi-Valensi P, 
Zielinski J, Delaunois L, Cornudella R,Moutinho dos Santos J, A randomized trial of nocturnal 
oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J 1999; 14(5): 
1002-8. 
5. Uronis HE, Ekstrom MP, Currow DC, McCrory DC, Samsa GP,Abernethy AP, Oxygen for relief 
of dyspnoea in people with chronic obstructive pulmonary disease who would not qualify for 
home oxygen: a systematic review and meta-analysis. Thorax 2015; 70(5): 492-4. 
6. Somfay A, Porszasz J, Lee SM,Casaburi R, Dose-response effect of oxygen on hyperinflation 
and exercise endurance in nonhypoxaemic COPD patients. Eur Respir J 2001; 18(1): 77-84. 
7. O'Donnell DE, Bain DJ,Webb KA, Factors contributing to relief of exertional breathlessness 
during hyperoxia in chronic airflow limitation. American Journal of Respiratory and Critical 
Care Medicine 1997; 155(2): 530-535. 
8. Cotes JE,Gilson JC, Effect of oxygen on exercise ability in chronic respiratory insufficiency; use 
of portable apparatus. Lancet 1956; 270(6928): 872-6. 
9. Bradley JM,O'Neill B, Short-term ambulatory oxygen for chronic obstructive pulmonary 
disease. Cochrane Database Syst Rev 2005(4): Cd004356. 
10. Marcus CL, Bader D, Stabile MW, Wang CI, Osher AB,Keens TG, Supplemental oxygen and 
exercise performance in patients with cystic fibrosis with severe pulmonary disease. Chest 
1992; 101(1): 52-7. 
11. Garrod R, Paul EA,Wedzicha JA, Supplemental oxygen during pulmonary rehabilitation in 
patients with COPD with exercise hypoxaemia. Thorax 2000; 55(7): 539-43. 
12. Rooyackers JM, Dekhuijzen PN, Van Herwaarden CL,Folgering HT, Training with 
supplemental oxygen in patients with COPD and hypoxaemia at peak exercise. Eur Respir J 
1997; 10(6): 1278-84. 
13. Emtner M, Porszasz J, Burns M, Somfay A,Casaburi R, Benefits of Supplemental Oxygen in 
Exercise Training in Nonhypoxemic Chronic Obstructive Pulmonary Disease Patients. 
American Journal of Respiratory and Critical Care Medicine 2003; 168(9): 1034-1042. 
14. Spielmanns M, Fuchs-Bergsma C, Winkler A, Fox G, Kruger S,Baum K, Effects of Oxygen 
Supply During Training on Subjects With COPD Who Are Normoxemic at Rest and During 
Exercise: A Blinded Randomized Controlled Trial. Respir Care 2015; 60(4): 540-8. 
15. Alison JA, McKeough ZJ, Leung RWM, Holland AE, Hill K, Morris NR, Jenkins S, Spencer LM, 
Hill CJ, Lee AL, Seale H, Cecins N,McDonald CF, Oxygen compared to air during exercise 
training in COPD with exercise-induced desaturation. European Respiratory Journal 2019: 
1802429. 
16. Borg GA, Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14(5): 377-
81. 
17. Nolan CM, Maddocks M, Canavan JL, Jones SE, Delogu V, Kaliaraju D, Banya W, Kon SSC, 
Polkey MI,Man WD, Pedometer Step Count Targets during Pulmonary Rehabilitation in 
Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial. Am J Respir Crit Care 
Med 2017; 195(10): 1344-1352. 
18. Curtis KJ, Meyrick VM, Mehta B, Haji GS, Li K, Montgomery H, Man WD, Polkey 
MI,Hopkinson NS, Angiotensin-Converting Enzyme Inhibition as an Adjunct to Pulmonary 
Rehabilitation in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2016; 
194(11): 1349-1357. 
19. Man WD, Soliman MG, Gearing J, Radford SG, Rafferty GF, Gray BJ, Polkey MI,Moxham J, 
Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive 
pulmonary disease. Am J Respir Crit Care Med 2003; 168(5): 562-7. 
20. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, 
Man WD-C, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen FME, Casaburi R, 
Vercoulen JH, Vogiatzis I, Gosselink R, Clini EM, Effing TW, Maltais F, Palen Jvd, Troosters T, 
Janssen DJA, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, Puhan MA, Hoogendoorn M, 
Garrod R, Schols AMWJ, Carlin B, Benzo R, Meek P, Morgan M, Mölken MPMHR-v, Ries AL, 
Make B, Goldstein RS, Dowson CA, Brozek JL, Donner CF,Wouters EFM, An Official American 
Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in 
Pulmonary Rehabilitation. American Journal of Respiratory and Critical Care Medicine 2013; 
188(8): e13-e64. 
21. Bolton CE, Bevan-Smith EF, Blakey JD, Crowe P, Elkin SL, Garrod R, Greening NJ, Heslop K, 
Hull JH, Man WD-C, Morgan MD, Proud D, Roberts CM, Sewell L, Singh SJ, Walker 
PP,Walmsley S, British Thoracic Society guideline on pulmonary rehabilitation in adults: 
accredited by NICE. Thorax 2013; 68(Suppl 2): ii1-ii30. 
22. Alison JA, McKeough ZJ, Johnston K, McNamara RJ, Spencer LM, Jenkins SC, Hill CJ, 
McDonald VM, Frith P, Cafarella P, Brooke M, Cameron-Tucker HL, Candy S, Cecins N, Chan 
AS, Dale MT, Dowman LM, Granger C, Halloran S, Jung P, Lee AL, Leung R, Matulick T, 
Osadnik C, Roberts M, Walsh J, Wootton S,Holland AE, Australian and New Zealand 
Pulmonary Rehabilitation Guidelines. Respirology 2017; 22(4): 800-819. 
 
 
 
 
 
 
 
 
